BALORAMOTIDE

UNII: 9T6PW6J6MA
Preferred Substance Name: BALORAMOTIDE

2207581-19-7
AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, RECOMBINANT
BALORAMOTIDE [INN]
CANCER TESTIS ANTIGEN NY-ESO-1 (RECOMBINANT HUMAN)
CANCER/TESTIS ANTIGEN 1, RECOMBINANT
GLYCYL-L-PROLYL-HUMAN CANCER/TESTIS ANTIGEN 1 (AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, L ANTIGEN FAMILY MEMBER 2 (LAGE-2), CANCER/TESTIS ANTIGEN 6.1, CT6.1)
L ANTIGEN FAMILY MEMBER 2, RECOMBINANT
LAGE-2, RECOMBINANT
RECOMBINANT NY-ESO-1 PROTEIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

BALORAMOTIDE

Synonyms and Mappings

Resources

Note